Market Is Estimated To Witness High Growth Owing To Its Promising Pipeline And Strong R&D Investments.

 
Antibody Drug Conjugates

The Antibody Drug Conjugates Market is estimated to be valued at US$ 5.38 billion in 2023 and is expected to exhibit a CAGR of 14.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Antibody-drug conjugates (ADCs) are bioconjugate compounds used for targeted drug delivery. They consist of monoclonal antibodies attached to a small-molecule drug or cytotoxic agent. The monoclonal antibody helps target the cancer cells and the cytotoxic agent then kills those cells. ADCs help deliver highly potent anti-cancer drugs directly to the tumor while limiting side effects in non-cancerous cells.

Market Dynamics:
The growing antibody drug conjugates market is driven primarily by its promising pipeline and strong R&D investments from major players. Several late-stage pipelines are expected to be commercialized during the forecast period, propelling market growth. For instance, AstraZeneca's Enhertu was approved in 2019 for HER2-positive breast cancer and non-small cell lung cancer indications. Furthermore, rising incidence of cancer worldwide has increased demand for targeted therapies like ADCs. Moreover, approvals of novel ADCs to treat blood cancers and solid tumors are also augmenting the market growth. However, high costs associated with developing ADCs and complex manufacturing processes pose challenges to market players.

SWOT Analysis
Strength: Antibody-drug conjugates allow targeted drug delivery to cancer cells. By attaching cytotoxic drugs to monoclonal antibodies, ADCs minimize damage to healthy cells. ADCs have high specificity and selectivity for tumor cells. Longer patent life of novel ADC over conventional chemotherapy drugs.
Weakness: High research and development costs associated with developing ADCs. Complex manufacturing processes require specialized infrastructure and expertise. Issues related to linker stability and drug-antibody ratio.
Opportunity: Large patient pool suffering from cancers drives demand for therapies with improved safety profiles over conventional chemotherapy. Increasing healthcare expenditure in developing countries to boost market growth. Growing pipeline of ADC candidates in clinical trials indicates potential for market expansion.
Threats: Stringent regulatory approvals require extensive clinical data, delaying market entry. Biosimilar competition once ADC patents expire poses pricing challenges. Adverse effects seen with some approved ADCs limit their adoption.

Key Takeaways
The  Global Antibody Drug Conjugates Market is expected to witness high growth, exhibiting CAGR of 14.2% over the forecast period, due to increasing demand for targeted cancer therapies with fewer side effects.

Regional analysis
The US dominates the global ADC market, accounting for majority market share, owing to presence of advanced healthcare infrastructure and favorable reimbursement policies. Asia Pacific is the fastest growing regional market due to rising healthcare expenditure, improving diagnostic capabilities and growing patient pool.

Key players
Key players operating in the Antibody Drug Conjugates market are AstraZeneca PLC, Daiichi Sankyo Company, Limited, Novasep, ADC Therapeutics SA, Alentis Therapeutics AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., AbbVie Inc., Biosion USA, Inc., Astellas Pharma Inc., Duality Biologics (Suzhou) Co. Ltd., BioNTech SE, LaNova Medicines Ltd., Bliss Biopharmaceutical, Eisai Co., Ltd., ProfoundBio, Pfizer, Inc., ImmunoGen Inc., Mersana Therapeutics Inc., Sorrento Therapeutics Inc., Oxford BioTherapeutics Ltd, and Takeda Pharmaceutical Company Ltd.

Read More - https://www.dailyprbulletin.com/the-promise-of-precision-medicine-antibody-drug-conjugates-pave-the-way-for-highly-targeted-cancer-therapies-growth/

Comments

Post a Comment

Popular posts from this blog

Optical Transport Network Market Is Estimated To Witness High Growth Owing To Opportunity In Deployment Of 400G Systems

Image
Optical Transport Network Market  Optical transport network (OTN) refers to the transport of data, voice and video traffic over long distances using optical technologies. OTN solutions facilitate transmission bandwidth rates ranging from 10Gbit/s to over 100Gbit/s over existing fiber infrastructure. They deploy advanced multiplexing techniques such as dense wave division multiplexing (DWDM) and time-division multiplexing (TDM) that boost transmission and switching capabilities. OTN solutions deliver reduced latency and enhanced reliability for meeting rising bandwidth demands. The global Optical Transport Network Market is estimated to be valued at US$ 22.32 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising deployment of 400G networks across internet data centers and telecom backbones is estimated to present lucrative growth opportuniti...
Read more

Ostomy Care Accessories Market Is Estimated To Witness High Growth Owing To Opportunity In Improving Patient Lifestyles

Image
Ostomy Care Accessories Market Ostomy accessories are medical devices used along with an ostomy appliance or pouching system to help improve the quality of life of people who have had ostomy surgery. Some common ostomy accessories include belt or pants/undergarment clips, skin barriers, moisture-collecting bags, adhesive removers, and protecting sheets. The growing number of patients suffering from inflammatory bowel disease, colorectal cancer, and other gastrointestinal disorders have resulted in increasing demand for ostomy care accessories. These accessories play a crucial role in providing security, discretion, and comfort to ostomates while performing regular activities. The global Ostomy Care Accessories Market is estimated to be valued at US$ 3.69 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Improving patient lifestyles is one of the major...
Read more

Schmallenberg Virus Treatment Is Estimated To Witness High Growth Owing To Opportunity Of Development Of New Drugs And Vaccines

Image
Schmallenberg Virus Treatment Market Schmallenberg virus (SBV) is an orthobunyavirus that affects domestic and wild ruminants such as cattle, sheep and goats. The virus causes fever, diarrhea and decreased milk production in adult animals. In newborn animals, the virus can lead to arthrogryposis-hydranencephaly syndrome, which causes malformations of the limbs and heads. While there is currently no treatment for SBV infection, supportive treatment measures such as nutritional supplements can help address symptoms such as diarrhea and reduced milk production. Researchers are developing preventive drugs and vaccines to control the spread of the virus. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity for growth in the Schmallenberg virus treatment marke...
Read more